Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:ICVX Icosavax (ICVX) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Icosavax Stock (NASDAQ:ICVX) 30 days 90 days 365 days Advanced Chart Get Icosavax alerts:Sign Up Key Stats Today's Range$15.31▼$15.3150-Day Range$15.31▼$15.4552-Week Range$4.75▼$16.10VolumeN/AAverage Volume1.22 million shsMarket Capitalization$766.88 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewIcosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases through virus-like particle (VLP) platform technology. Its lead product candidate IVX-A12, a respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) VLP vaccine. The company also develops IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; and IVX-241, a vaccine candidate with hMPV target. Icosavax, Inc. was incorporated in 2017 and is headquartered in Seattle, Washington. As of February 19, 2024, Icosavax, Inc. operates as a subsidiary of AstraZeneca PLC.Read More… Receive ICVX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Icosavax and its competitors with MarketBeat's FREE daily newsletter. Email Address ICVX Stock News HeadlinesAssembly Biosciences (NASDAQ:ASMB) Stock Quotes, Forecast and News SummarySeptember 24, 2024 | benzinga.comFrazier Life Sciences Adds Industry Veteran and Serial Dealmaker, Adam Simpson, to Company Creation TeamSeptember 20, 2024 | finance.yahoo.com#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... But today, Chris is now making the biggest crypto call of his ENTIRE career…January 5, 2025 | True Market Insiders (Ad)Vaxcyte Inc Ordinary Shares 5VAAugust 2, 2024 | morningstar.comNervGen Pharma Corp Ordinary Shares NGENApril 21, 2024 | morningstar.comCHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB)March 20, 2024 | markets.businessinsider.comIcosavax: Tender Offer With Contingent Value RightFebruary 11, 2024 | seekingalpha.comIcosavax CVR Seems Fairly ValuedJanuary 5, 2024 | seekingalpha.comSee More Headlines ICVX Stock Analysis - Frequently Asked Questions How were Icosavax's earnings last quarter? Icosavax, Inc. (NASDAQ:ICVX) released its quarterly earnings results on Monday, November, 15th. The company reported ($1.30) EPS for the quarter, missing analysts' consensus estimates of ($0.49) by $0.81. The business earned $1.83 million during the quarter, compared to the consensus estimate of $3.30 million. When did Icosavax IPO? Icosavax (ICVX) raised $150 million in an initial public offering (IPO) on Thursday, July 29th 2021. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. What other stocks do shareholders of Icosavax own? Based on aggregate information from My MarketBeat watchlists, some other companies that Icosavax investors own include American Water Works (AWK), The RMR Group (RMR), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC), Waste Connections (WCN), AUO (AUOTY) and Triple Flag Precious Metals (TFPM). Company Calendar Last Earnings11/15/2021Today1/05/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolNASDAQ:ICVX CUSIPN/A CIK1786255 Webicosavax.com Phone206-737-0085FaxN/AEmployees60Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.22) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-91,760,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-43.06% Return on Assets-39.53% Debt Debt-to-Equity RatioN/A Current Ratio18.06 Quick Ratio18.06 Sales & Book Value Annual Sales$580,000.00 Price / Sales1,322.20 Cash FlowN/A Price / Cash FlowN/A Book Value$5.47 per share Price / Book2.80Miscellaneous Outstanding Shares50,090,000Free Float34,767,000Market Cap$766.88 million OptionableOptionable Beta1.28 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report This page (NASDAQ:ICVX) was last updated on 1/5/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAmazon coin set to soar 25X – starting January 20thThis tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. ...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Icosavax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Icosavax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.